AAAAAA

   
Results: 1-5 |
Results: 5

Authors: de Kleijn, E van Eijndhoven, L Vermont, C Kuipers, B van Dijken, H Rumke, H de Groot, R van Alphen, L van den Dobbelsteen, G
Citation: E. De Kleijn et al., Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesiclevaccine, VACCINE, 20(3-4), 2001, pp. 352-358

Authors: Kuipers, B van den Dobbelsteen, G Wedege, E van Alphen, L
Citation: B. Kuipers et al., Serological characterization, METH MOL M, 67, 2001, pp. 131-145

Authors: Stittelaar, KJ Boes, J Kersten, GFA Speikstra, A Mulder, PGH de Vries, P Roholl, PJM Dalsgaard, K van den Dobbelsteen, G van Alphen, L Osterhaus, ADME
Citation: Kj. Stittelaar et al., In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components, VACCINE, 18(23), 2000, pp. 2482-2493

Authors: de Kleijn, ED de Groot, R Labadie, J Lafeber, AB van den Dobbelsteen, G van Alphen, L van Dijken, H Kuipers, B van Omme, GW Wala, M Juttmann, R Rumke, HC
Citation: Ed. De Kleijn et al., Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age, VACCINE, 18(15), 2000, pp. 1456-1466

Authors: van der Voort, ER Schuller, M Holst, J de Vries, P van der Ley, P van den Dobbelsteen, G Poolman, J
Citation: Er. Van Der Voort et al., Immunogenicity studies with a genetically engineered hexavalent PorA and awild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys, VACCINE, 18(14), 2000, pp. 1334-1343
Risultati: 1-5 |